Premium
Prexige: new coxib for OA, dysmenorrhoea and acute pain
Author(s) -
Scott David
Publication year - 2006
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.422
Subject(s) - medicine , osteoarthritis , acute pain , physical therapy , alternative medicine , anesthesia , pathology
Lumiracoxib (Prexige) is a new COX‐2 inhibitor that is currently licensed for use in osteoarthritis (OA), primary dysmenorrhoea and acute pain. Here, Professor Scott focusses on its safety and efficacy and discusses its role in managing pain in OA patients. Copyright © 2006 Wiley Interface Ltd